Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Poston L, Bell R, Briley AL, et al. Improving pregnancy outcome in obese women: the UK Pregnancies Better Eating and Activity randomised controlled Trial. Southampton (UK): NIHR Journals Library; 2017 Apr. (Programme Grants for Applied Research, No. 5.10.)
Improving pregnancy outcome in obese women: the UK Pregnancies Better Eating and Activity randomised controlled Trial.
Show detailsFollowing development of the intervention, detailed in this chapter and the protocol (see Chapter 4), the programme progressed to phase 2, a pilot trial designed to establish the efficacy of the intervention in changing dietary and PA behaviours and to evaluate all practical aspects of delivering the intervention.
This chapter has been published as Poston L, Briley AL, Barr S, Bell R, et al. Developing a complex intervention for diet and activity behaviour change in obese pregnant women (the UPBEAT trial); assessment of behavioural change and process evaluation in a pilot randomised controlled trial. BMC Pregnancy Childbirth 2013;13:148.150 © Poston et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The text below includes minor additions and formatting changes to the original text.
Abstract
Background: Complex interventions in obese pregnant women should be theoretically based, feasible and shown to demonstrate expected behavioural change prior to inception of large RCTs. The aim was to determine if (1) a complex intervention in obese pregnant women leads to expected changes in diet and PA behaviours, and (2) to refine the intervention protocol through process evaluation of intervention fidelity.
Methods: We undertook a pilot RCT of a complex intervention in obese pregnant women, comparing routine antenatal care with an intervention to reduce dietary GL and saturated fat intake and increase PA. Subjects included 183 obese pregnant women (mean BMI 36.3 kg/m2). Diet was assessed by repeated triple-pass 24-hour dietary recall and PA by accelerometry and questionnaire at 16+0–18+6 and at 27+0–28+6 weeks’ gestation in women in control and intervention arms. Attitudes to behaviour change and quality of life were assessed and a process evaluation undertaken. The full RCT protocol was undertaken to assess feasibility.
Results: Compared with women in the control arm, women in the intervention arm had a significant reduction in dietary GL (33 points, 95% CI −47 to −20 points), (p < 0.001) and saturated fat intake (−1.6% energy, 95% CI −2.8% to −0.3%) at 28 weeks’ gestation. Objectively measured PA did not change. Physical discomfort and sustained barriers to PA were common at 28 weeks’ gestation. Process evaluation identified barriers to recruitment, group attendance and compliance, leading to modification of intervention delivery.
Conclusions: This pilot trial of a complex intervention in obese pregnant women suggests greater potential for change in dietary intake than for change in PA, and through process evaluation illustrates the considerable advantage of performing an exploratory trial of a complex intervention in obese pregnant women before undertaking a large RCT.
Trial registration: Trial registration number ISRCTN89971375.
Background
Obesity is prevalent in women of reproductive age in both high- and low- to middle-income countries.82 Obese pregnant women have a heightened risk of adverse pregnancy outcomes,82 but at present there is no evidence-based intervention that can be introduced into clinical practice to improve pregnancy outcome in obese women. The majority of attempts to develop interventions have hitherto focused on limiting GWG in accordance with the US Institute of Medicine’s recommendations.83 Recent meta-analyses of relevant studies in obese women show modest restriction of GWG without robust evidence for improved clinical outcome.84,85 Limitations of the existing evidence include poor study design, small sample size, absence of a theoretical basis and, importantly, no a priori demonstration of the feasibility of the intervention in regard to changing the specific behaviours targeted. We have developed a theoretically based behavioural group intervention (diet and PA) for obese pregnant women with the primary aim of improving maternal glucose homeostasis. As maternal insulin resistance is integral to many complications of obese pregnancy, the dietary intervention focuses on lowering the dietary GI, previously shown to improve pregnancy outcome in women with GDM.9,86 Recommendations were also made to lower saturated fat intake, as a diet high in saturated fats has been implicated in insulin resistance and GDM.87 Increased PA can also improve metabolic control and reduce GDM risk in pregnant women.88
Prior to embarking on a large RCT, and in accordance with UK Medical Research Council Guidance for development of a complex intervention,89 we first explored the theoretical basis for an intervention in obese pregnant women,2,3,85,90 leading to development of a novel intervention (phase 1). We now report on phase 2, an exploratory trial to determine whether or not this intervention achieved the changes in dietary and PA behaviours expected, and to undertake a process evaluation of every aspect of fidelity of the intervention and the protocol.
Participants
Potentially eligible participants attending clinics for general antenatal care were approached by research midwives in four UK study centres in urban settings providing a range of models of care. The contributing hospitals were (1) The Southern General Hospital and Princess Royal Maternity Hospital (Glasgow), (2) The Royal Victoria Infirmary (Newcastle), (3) Guy’s and St Thomas’ NHS Foundation Trust (London) and (4) King’s College Hospital Foundation Trust (London).
Methods
The protocol for the exploratory trial is shown in Figure 3. Verbal and printed information was provided to potential participants at a routine antenatal appointment in the first trimester of pregnancy and women were contacted > 24 hours later to ascertain willingness to participate. For those declining participation, consent to record basic demographic data and BMI was obtained. Those willing to participate were invited to return for their first study appointment in the early second trimester (> 15+0 to < 17+6 weeks’ gestation). This window of recruitment allowed adequate time for arrangement of the one-to-one session with the HT followed by the 8-week intervention programme prior to the oral glucose tolerance test (OGTT), carried out between 27+0 and 28+6 weeks’ gestation. Research midwives received a study-specific manual, attended at least one training session with the trial manager and continued feedback and training sessions for the study duration.
Inclusion criteria: a BMI of ≥ 30 kg/m2, singleton pregnancy and a gestational age of > 15+ and < 17+6 weeks.
Exclusion criteria: unable or unwilling to give written informed consent; gestation age of < 15+0 and > 17+6 weeks; pre-existing diabetes mellitus; pre-existing essential hypertension (treated); pre-existing renal disease; multiple pregnancy; systemic lupus erythematosus; antiphospholipid syndrome; sickle cell disease; thalassaemia; coeliac disease; currently prescribed metformin; thyroid disease; or current psychosis.
All data were entered onto a password-protected secure database (MedSciNet Ltd). Randomisation was performed online. The randomised treatment was allocated automatically, balanced by minimisation for maternal age, centre, ethnicity, parity and BMI. Data were analysed using Stata (version 11.2; StataCorp, College Station, TX, USA). All women randomised between 29 March 2010 and 13 May 2011 were included. Postcodes were matched to two national indices of deprivation: the Index of Multiple Deprivation91 for English addresses or the Scottish Index of Multiple Deprivation92 for addresses in Scotland.
Control arm
Following randomisation, women in the control arm (standard care) returned for data collection appointments with the study midwife at 27+0–28+6 and 34+0–36+6 weeks’ gestation, when possible coinciding with routine antenatal visits.
Intervention arm
Following randomisation, participants attended a one-to-one appointment with the HT and were invited to weekly group sessions for 8 consecutive weeks from approximately 19 weeks’ gestation. All women attended routine antenatal care appointments and received advice regarding diet and PA in accordance with local policies, which draw on the UK’s National Institute for Health and Care Excellence (NICE)’s guidelines.93
Sample size
The primary outcome was change in dietary and PA behaviours at 28 weeks’ gestation (coinciding with the primary maternal outcome for the main RCT, GDM at 28 weeks’ gestation). No prior investigation in obese pregnant women was available to inform power at the planning stage. The sample size of 183 was determined by the predefined duration of phase 2, the exploratory phase. This number was adequate to enable power calculations for primary end points of the subsequent RCT, by providing estimates of the variance to within approximately 7% of the true value.
Ethics
Research Ethics Committee approval was obtained in all participating centres, UK IRAS reference number 09/H0802/5 (South East London Research Ethics Committee).
The intervention
The intervention was informed by psychological models of health behaviour including control theory94 and social cognitive theory.95 Although no clear patterns between intervention characteristics and outcomes have been seen to date in lifestyle interventions in pregnancy, and few studies have described their theoretical basis,2,85 self-regulation techniques, drawn from control theory, suggest that behaviour change is facilitated by feedback about performance compared with prespecified goals.94,96 This approach was utilised in this study by setting specific, measurable, achievable, relevant and time-specific (SMART) diet and activity goals, with behaviours recorded in a logbook. Identification of benefits of, and overcoming barriers to, behaviour change, and increasing self-efficacy were also included, and social support was facilitated through the group format.95 As identified in social cognitive theory, the intervention aimed to build self-efficacy through mastery experiences (e.g. maximising the chance of success with SMART goals), vicarious experiences (encouraged through modelling in the group setting), and social persuasion (e.g. through enlisting social support). Following initial feedback from HTs regarding difficulties encountered by some women in attending sessions, for those women unable to attend, the session content was delivered by telephone or e-mail.
Dietary advice
Prespecified dietary outcomes were a change in the GI, GL [an indicator of carbohydrate quality (GI) and quantity consumed] and energy intake from saturated fatty acids (SFAs). The focus of the dietary advice to the intervention group was therefore on increased consumption of foods with a low dietary GI, including replacement of sugar-sweetened beverages with low-GI alternatives. Reduction in saturated fats and replacement with monounsaturated and polyunsaturated fat was also recommended. Exchange of foods was emphasised, for example a high-GI food for a low-GI food, rather than limiting energy intake.
Physical activity advice
Women in the intervention arm were encouraged to increase daily PA incrementally, setting goals of incremental step counts (monitored by pedometer) and maintaining the achieved PA level after the intervention period. Recommendations included an emphasis on walking at a moderate-intensity level.39
Intervention delivery
The intervention was delivered by HTs. In the UK, HTs do not have prespecified health professional qualifications, but relevant experience [http://informationstrategy.dh.gov.uk/health-trainer-workforce (last accessed 10 March 2013), information now available at www.healthcareers.nhs.uk/explore-roles/public-health/health-trainer (last accessed 20 March 2017)]. All HTs received a comprehensive treatment manual, pre-study training (and within-study supervision) in behaviour modification and conducting group sessions (organised by Weight Concern; registered charity number 1059686). The sessions were held in a hospital setting in all but one centre, in which women attended a community children’s centre. At the initial one-to-one appointment women were provided with a participant handbook, reflecting the rationale and content of the HT sessions, a pedometer (Yamax SW200 Digi-Walker), a logbook for weekly SMART goals and related behaviours (steps, PA and diet) and a DVD of a specially devised pregnancy exercise regime. Potential benefits of attending group sessions were discussed. Each group session delivered a different element of the dietary and PA intervention. (Table 7). Goals from the previous week were reviewed and goals set for the following week. Discussion included barriers to behavioural change and ways these might be overcome.
The following information was obtained from all participants (at visits indicated in Figure 3).
Attitudinal assessment questionnaire
The attitudinal assessment included questions relating to perceived benefits and barriers and confidence to carry out the dietary and PA behaviours.27,97 The target behaviours were to consume lower-GI carbohydrates, to reduce saturated fat intake and to increase PA.
Health status and mental health
The EQ-5D98 was used to assess health status and the Edinburgh Postnatal Depression Scale (EPDS) to assess mental health.99
Dietary assessment
Repeated, triple-pass 24-hour recall data obtained at baseline (randomisation) and at 28 weeks’ gestation were evaluated twice, 1 week apart, in both the intervention and control groups. The 24-hour dietary recall is a standard retrospective, interviewer-led dietary assessment methodology used to capture information on all food and drinks consumed in the preceding 24 hours. This is carried out in three stages (the triple pass): (1) recording a ‘quick’ list of foods eaten or drunk, (2) collecting more detailed information of these foods and (3) reviewing all items once more in order to clarify any ambiguities or omissions. A short FFQ, for later validation, was also completed.
Physical activity assessment
At the first and third appointments participants were asked to wear an ActiGraph accelerometer (either GT1M or GT3X set to uniaxial mode) for 7 consecutive days, removing it for washing, bathing, swimming and at night. PA was also assessed by questionnaire [via the Recent Physical Activity Questionnaire (RPAQ)].
Process evaluation
A process evaluation, following the framework of Steckler and Linnan,100 was undertaken. This explored (1) context (environmental, socioeconomic or political factors), (2) reach (the proportion of the intended target audience that participates and which subgroups, if any, do not participate), (3) dose delivered and dose received (the proportion of intended intervention received), (4) fidelity (if each component of the complex intervention was provided as intended) and (5) acceptability (if the intervention materials and advice were well-received by providers and participants).
Qualitative semistructured interviews were conducted to capture women’s experiences and perceptions of the trial and intervention. Women were recruited from each of the participating study sites using a maximum diversity sampling approach, following an informed consent procedure. Interviews took place between November 2010 and February 2011, and were either face to face (n = 17), mostly in hospital settings, or by telephone (n = 4). Control (n = 12) and intervention (n = 9) interviewees were asked about their involvement in the research and their experiences of the trial appointments, measurements, blood tests and accelerometry recordings. Women in the intervention arm were additionally asked about their perceptions of the different components of the intervention, and how these impacted upon their lives. The interviews were conducted by one researcher and took place during pregnancy after the intervention had been provided. In addition, HTs completed audio diaries (130 recordings) in which they reflected on the fidelity and feasibility of the intervention delivery. Attendance at sessions was recorded on the study database.
Clinical outcome data
Maternal primary outcome for the subsequent randomised controlled trial (diagnosis of gestational diabetes mellitus)
A blood sample for fasting glucose and insulin was taken after an overnight fast. For the OGTT, following a glucose load [410 ml of Lucozade (Suntory Holdings Ltd, Osaka, Japan) or 75 g of glucose in water], 1-hour and 2-hour samples were taken for glucose measurement. Diagnosis of GDM was confirmed by a fasting glucose level of ≥ 5.1 mmol/l and/or 1-hour glucose level of ≥ 10 mmol/l or 2-hour glucose level of ≥ 8.5 mmol/l, in accordance with the International Association of the Diabetes and Pregnancy Study Groups (IADPSG)’s guidelines.6 Following GDM diagnosis, women were referred for routine GDM care in accordance with local criteria.
Neonatal primary outcome for the subsequent randomised controlled trial (large-for-gestational age delivery defined as ≥ 90th customised birthweight centile)
Customised birthweight centiles were calculated correcting for gestational age, maternal ethnicity, weight and height in early pregnancy, parity and infant sex. Weight adjustment for women with a BMI of ≥ 30 kg/m2 is based on a notional weight corresponding to a BMI of 29.9 kg/m2.
Outcome data also recorded (not reported)
These included maternal outcomes: diagnosis of GDM and pre-eclampsia, mode of delivery, blood loss at delivery, inpatient nights, detailed clinical and family history, health in current pregnancy, early pregnancy data (ultrasound scan, nuchal screening), blood pressure, routine blood results; neonatal outcomes: gestational age at delivery, birthweight, anthropometry and inpatient nights. Maternal urine and cord blood samples were also provided.
Data handling and statistical analysis
Health quality and attitudinal assessment questionnaires
The generic EQ-5D health-related quality-of-life instrument98 is reported as the proportion of women with problems on individual dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). It is given as a summary index score calculated from preference values of different combinations of the dimensions elicited using the time trade-off method in a sample representative of non-institutionalised adults in England, Scotland and Wales (range −0.59 to 100, where −0.59 is severe problems on all dimensions);101,102 and also the visual analogue scale of health-related quality of life (range 0 to 100, where 0 is worst imaginable health state). The change between baseline and 28 weeks’ gestation in the percentage of women with any problem was assessed using McNemar’s test of changes. Attitudes to target behaviours (attitudinal assessment questionnaire) are based on the average of multiple responses on five-point scales (three responses for diet, 13 for PA) with five indicating the greatest perceived barrier, perceived benefit or level of confidence.
Assessment of deprivation
These scales for estimation of deprivation in England and Scotland91,92 use different reference populations to determine the actual indices of deprivation, and are therefore not directly comparable. For the purposes of this study, the most deprived quintile is presented separately for women in each population and compared with the remainder of the population (quintiles 1–4).
Dietary analysis
The quality of dietary data was checked within 1 week of entry. Dietary coding utilised McCance and Widdowson’s Composition of Foods (6th edition)103 food codes and nutrient composition was evaluated using WISP version 3 for GI and GL values.104 Estimates using previously published methodology were made when GI values were not available.105 Twenty-four-hour recall data obtained at baseline (randomisation) and at 28 weeks’ gestation were evaluated twice, 1 week apart, and then averaged. The validity of the short FFQ was assessed against the dietary recall data. Prespecified dietary outcomes were a change in GI, GL and energy intake from SFA. Total energy intake and the proportion of energy derived from macronutrients were assessed. GWG at 28 and 36 weeks’ gestation, a relevant secondary outcome of interest, is also reported.
ActiGraph analysis
An epoch length (time sampling interval) of 15 seconds was specified. Data were processed using the MAHuffe software package. Sedentary behaviour was defined as < 100 cpm, light activity as 100–1951 cpm, moderate-intensity activity as 1952–5725 cpm and vigorous activity as > 5725 cpm.68 As time spent in vigorous activity was very low, minutes of moderate and vigorous physical activity (MVPA) were combined. Runs of zero counts lasting > 60 minutes were excluded, as these indicated monitor removal. A valid recording was defined as a day in which > 500 minutes of monitored on-time was recorded in 24 hours.106 Data from participants recording ≥ 3 days of valid accelerometry data on 3 or more days were included in the analysis. The specified PA outcome was an increase in minutes per day of MVPA recorded by accelerometry.
Recent Physical Activity Questionnaire
The RPAQ was modified for the assessment of PA in the preceding 7 days. Estimates of minutes per day spent in light, moderate and vigorous activity in each of the domains were calculated. Sedentary activities were defined as those with a metabolic equivalent (MET) of < 1.5. Light activities were those of 1.5–3 METs. Moderate activities were those of 3–6 METs. Vigorous activities were those of 6 METs or greater.107 MVPAs were combined to give one summary variable.
Process evaluation
Interviews were recorded and transcribed verbatim. Transcripts were anonymised and a unique identifier (ID) number was used to maintain confidentiality. Data were imported into a qualitative software analysis package (NVivo version 8, QSR International, Warrington, UK) and subject to comparative thematic analysis.108 To enhance study validity and reliability, themes arising from the research were discussed, the data supporting these were reviewed by co-researchers, and data were compared between sites and with existing literature. By these methods, assumptions were tested and observations of differences and their relationship to the theoretical models underpinning the study were explored.
Statistical analysis
Analyses followed the intention-to-treat principle. Following Consolidated Standards of Reporting Trials (CONSORT) guidelines, risk ratios and risk differences were estimated by binary regression for yes/no outcomes. When measures were repeated at baseline and 28 weeks’ gestation, results of mean [standard deviation (SD)] or n (%) are presented separately at each time point. Randomised comparisons at 28 weeks were made using linear regression with robust standard errors, adjusting for the baseline value. For PA data, dummy variables were used when the baseline values were missing. Correlations between PA as assessed objectively (accelerometry) and when self-reported (RPAQ) were explored.
Results
Figure 4 provides a flow chart of participants through the study.
Participants
The mean first visit BMI was 36.3 kg/m2. More than half the women were white and the remainder were from black (38%) and minority ethnic communities. More than half (56%) already had at least one child. More than half of those from centres in England and over 40% in Scotland came from regions in the highest quintile of social deprivation (Table 8).
Diet and gestational weight gain
Table 9 shows the dietary intakes at baseline and at 28 weeks’ gestation. There were no differences between groups in energy intakes, GI, GL or other macronutrient at baseline. However, following the intervention, at 28 weeks’ gestation, total energy intake, dietary GL, GL (% energy), saturated fat (% energy) and total fat (% energy) were significantly lower, and fibre intake measured as non-starch polysaccharides was greater, in the intervention group than in the control arm. The proportion of energy derived from protein was higher in the intervention group, but absolute protein intake did not differ. There was a difference of 7 GI points between the intervention and control group, which achieved borderline statistical significance (p = 0.054).
There was a marginal difference in GWG of –0.9 kg between the intervention and control group at 28 weeks’ gestation (p = 0.065).
Physical activity
There were no differences between the intervention and the control arms in objectively measured PA variables at baseline or at 28 weeks’ gestation, after adjustment for baseline activity. Self-reported moderate to vigorous PA at 28 weeks’ gestation was increased in the intervention group (mean difference 34 minutes/day; 95% CI 9 to 59 minutes/day), but this was not supported by the objective data. Women in the intervention group self-reported walking for leisure for 14 minutes/day more than those in the control group at 28 weeks’ gestation (95% CI 5 to 23 minutes; p = 0.003). Agreement between the RPAQ questionnaire and accelerometry was very poor; for example, correlation between MVPA in the two formats at baseline was r = 0.275 (95% CI 0.107 to 0.428) and at 28 weeks’ gestation was r = −0.069 (95% CI –0.296 to 0.165) (Table 10).
Attitudinal assessment of target behaviours
Benefits, barriers and confidence in making the target PA and dietary changes were unchanged in either the control and intervention groups from baseline to 28 weeks’ gestation (Table 11).
Health Status, Mental Health Edinburgh Postnatal Depression Scale and EuroQol-5 Dimensions
There was no influence of the intervention on the numbers of women reporting problems in each of the EQ-5D domains, but, as a group, obese women experienced a significant increase in problems with mobility, self-care, usual activities and pain and discomfort from baseline to 28 weeks’ gestation. There was a 10% prevalence of probable depression at baseline and a 13% prevalence at 28 weeks (i.e. EPDS score of > 12), with no significant effect of the intervention on anxiety and depression at 28 weeks’ gestation (see Table 11).
Process evaluation
Context
This study coincided with the publication of new reports and guidance for obesity in pregnancy, with associated media coverage.93,109 Most control group interviewees demonstrated awareness and reported taking steps to improve their diet or fitness (Box 1).
Reach
The mean age of those approached who were eligible for recruitment but declined to participate (n = 473) was 29.9 years and their mean BMI was 35.39 kg/m2; 59.7% were white, and 32.8% were black and 43.0% were in the lowest quintile for the Index of Deprivation, indicating the most severe deprivation. The characteristics of participants providing semistructured interviews (n = 21) are shown in Table 12. Their demographic profile was similar to that of study participants (see Table 7). Overall, 29 out of 183 (15.8%) women were lost to follow-up (see Figure 4).
Dose
Of the 94 women randomised to the intervention, 82 (88%) attended at least one group session, and 60 (64%) attended four or more. A total of 42 women (45%) received material from all eight sessions, six by full attendance (6%) and the remainder when partly/wholly covered by subsequent telephone contact. The mean number of sessions attended or partly/wholly covered was 6.1 (SD 2.6).
Fidelity
The intervention package (eight HT group sessions) was provided with good consistency at each study site. Goals were set at all group sessions, of which 88% were considered SMART by HTs according to their diaries. The maximum group size was 5 (mean 2).
Acceptability
Women in both arms of the trial found the research processes acceptable and felt supported by the study midwives. Women in the intervention group were generally willing, in principle, to attend the eight HT sessions, and most women who attended valued the group approach, citing opportunities to raise questions and discuss each other’s experiences. Some were surprised at the extent of the intervention, having expected a less intensive, more advice-based approach. Consistency of attendance at the sessions varied for different reasons including work commitments, school pick-up times or feeling too unwell or tired. Occasionally initial involvement waned when groups proved smaller than expected, although the HT input by telephone or e-mail was considered valuable. Some women found the information contained in the handbook new, whereas for others it was too basic. The pedometers and step goals were generally well received. Setting and reflecting on weekly goals was motivational for most but could also invoke feelings of guilt, or a sense of being observed and judged. Women reported having watched the DVD, but few used it regularly.
When interviewees were asked whether or not they had made any changes as a result of the intervention, most reported some degree of change, especially in relation to dietary intake. Reported changes in PA were more limited, particularly because of pelvic pain or tiredness as pregnancy progressed. Women often reported aspirations to increase exercise postnatally (Box 2 and Table 13).
Maternal and neonatal outcomes
The primary maternal and neonatal outcomes for the subsequent RCT are shown in Table 13. There were no significant differences in GDM or LGA (≥ 90th customised centile) between control and intervention arms. There was also no significant difference in GWG between control and intervention arms (secondary outcome). The overall incidence of GDM, the primary outcome of the subsequent RCT (not powered for), in accordance with recent IADPSG criteria,6 was 30%, enabling calculation of the subsequent RCT sample size (1546 women) for the RCT, powered for a 25% reduction. As 38% of potentially eligible women took part in the pilot study, to achieve this sample size in the main RCT, approximately 4100 would need to be approached.
Discussion
This study describes a pragmatic and rigorously evaluated pilot study of a complex intervention for diet and activity behaviour change in obese pregnant women. The intervention was associated with a significant change in dietary behaviour. Process evaluation showed overall acceptability of the protocol, but led to several refinements to improve acceptability and fidelity.
In any lifestyle intervention of diet and PA, it is important that the pilot study design includes methods to assess the potential of the intervention to change these behaviours in the expected direction of effect. Few assessments of dietary intake in similar investigations of overweight or obese women have been attempted.110–112 We used a 24-hour recall method to assess dietary intake and, while this may lead to under-reporting of energy intakes, the reported values are not dissimilar to those of non-pregnant women in the general UK population.113 Both objectives of the dietary intervention, to bring about reductions in GL and the proportion of energy derived from SFAs, were achieved. This suggests that obese pregnant women are amenable to changing their diet in response to an intervention based on established theory, and that dietary advice, frequently delivered by health professionals, is likely to be successful in achieving dietary change in obese pregnant women, as previously implied.111 The reduction in dietary GL achieved was similar (33% vs. 45%) to that reported in obese type 2 diabetic non-pregnant subjects, in whom improved glycaemic control was achieved.114 Recently, a similar intervention in 759 pregnant women showed a lower change in GL (13%), which was associated with a reduction in GWG in women who had previously delivered a LGA infant.115
The reduction in energy intake observed is consistent with other studies that have restricted the intake of fat from meat and dairy products and which has not been replaced by other sources of food energy.116 The reduced GL may also have contributed through effects on satiety.117 To our knowledge this is the first study demonstrating that expected changes in diet occur following delivery of an intervention to lower GL and saturated fat in obese pregnant women without GDM. Importantly, this occurred despite the focus being on reducing GL by lowering the intake of added sugars as well as advocating foods with a lower GI. Focusing on GI tends to modify the GL from starch, whereas the GI from sugar-sweetened beverages is less amenable to change. Consequently, dietary advice to decrease the intake of added sugar, particularly as sugar-sweetened beverages, is likely to have had an important impact on GL.
This study adds to the scant literature on the habitual diet of obese pregnant women. The macronutrient profile at randomisation was similar to that of women in the general population, with fibre (non-starch polysaccharides) intake below, and total sugars and saturated fat above, recommended UK guidelines.118 The overall energy intake and macronutrient profile accords with one previous report in obese pregnant women.111 Because of the time required to rigorously assess diet using the 24-hour recall method, which, according to the process evaluation, is likely to have influenced recruitment and compliance, a short FFQ (5–10 minutes) was evaluated for use in the subsequent RCT.
The few studies that have attempted to measure changes in PA in intervention trials in pregnancy have generally relied on self-report, and results have been equivocal.111,119–122 Accelerometry, the standard method of objective assessment used previously in observational studies in pregnancy,121 has, to our knowledge, been employed in only one relevant RCT, the FitFor2 study,123 a supervised exercise intervention in 121 overweight and obese women. Consistent with the Fitfor2 study, we found no effect of the intervention on PA using the ActiGraph accelerometer, concurring with the reported absence of change in barriers to PA. The failure of accelerometry to mirror the increase in self-reported walking in the intervention group could reflect insufficient intensity of this activity, but also reporting bias49 that is common in the reporting of low-intensity activities, such as those frequently undertaken by pregnant women.44 As reported elsewhere, compliance with accelerometry in pregnancy was an issue.52,124
Nonetheless, 60% of obese pregnant women providing baseline accelerometry data met the current guidelines for PA in pregnancy (i.e. > 30 minutes of MVPA per day). A similar level of activity has been observed in pregnant women (all BMIs)52 and overweight and obese non-pregnant adults,125 but not previously among obese pregnant women. Levels of PA were similar to those we found previously among overweight and obese women,49 but substantially higher than those reported for non-pregnant women in the UK.126 There is no consensus on change of MVPA over pregnancy.51,124,127,128 In this study of obese women, both groups reduced the level of objectively measured MVPA as pregnancy progressed.
This assessment has highlighted a critical need to evaluate PA behaviour objectively. We may otherwise have erroneously concluded in the following RCT that increased PA does not affect clinically relevant outcomes. Despite showing no increase in PA, we have not recommended that the RCT focuses on diet only,84 but rather that women continue to be encouraged to adhere to PA recommended in clinical guidelines.
Although there were no changes in attitudinal outcomes, women were generally positive about the recommended dietary and PA behaviours despite perceived barriers to change. Attitudinal data relating to diet were comparable to those obtained in a population sample of pregnant women.3 The intervention did not achieve any reduction in perceived barriers but, despite this, important dietary changes were achieved, which may imply low levels of self-efficacy. However, barriers to increasing PA appeared too great to overcome, possibly reflecting increased physical discomfort with gestation, as indicated by the EQ-5D questionnaire.
The relationship between mental health, diet and PA in obese pregnancies warrants further investigation in the RCT in view of the high prevalence of depressive symptoms (EPDS score of > 12). Another report129 has also found no effect on these symptoms of a complex behavioural intervention in obese women.
In terms of context, the process evaluation recruited women in urban hospitals serving regions with areas of high socioeconomic deprivation. Obesity rates are higher among women with lower socioeconomic status and fewer qualifications130 and among particular ethnic groups, particularly black African and black Caribbean.131 It was important therefore to explore not only if recruitment was feasible, but also whether or not the intervention was acceptable to the women recruited. Prominent media coverage about obesity raised the possibility that women in the control group might proactively address diet and PA, and some interview data supported this, but the evaluation suggested that awareness through the media alone was not adequate to achieve sufficient behavioural change.
In relation to reach, just over one-third of eligible women agreed to participate. Similarly low recruitment rates are consistent with other intervention studies, particularly in populations with lower uptake of health care. In one previous relevant study of lifestyle advice in non-obese pregnant women, recruitment was slower than expected and low attendance at group exercise sessions and participant concern about burdensome data collection contributed to dropout.132 However, perceived advantages to participation such as extra clinical tests and continuity of care from research midwives supported study uptake and continuation. Given the continued rise in obesity in the adult population in England,130 approximately one in five pregnant women would be eligible for inclusion. Recruitment of the numbers needed to be approached (4100) for the full trial is therefore unlikely to be affected by a shortage of eligible women.
Overall, the wide social and ethnic diversity among participants was similar in participants and those who declined, indicating that the intervention would be unlikely to increase health inequalities by attracting more educated and higher-income participants.133 Importantly, although obese pregnant women, once recruited, were generally willing to attend group sessions, practicalities often interfered with regular attendance, thereby influencing dose.
However, the sessions did not appeal to all women. Some appreciated finding common issues with other group members, whereas others preferred one-to-one contact. Evidence for health improvement interventions in group settings is varied93 and this study adds to the recognition that a ‘one size fits all’ approach may not be effective,133 and that flexibility is key to retention. Fidelity was good with consistently high-level provision of SMART goals by HTs, which were viewed as a positive achievement, particularly since poor adherence to goal-setting has been associated with moderate attendance among pregnant women.134 The high acceptability of the participant handbook and pedometer reinforced the theoretical approach,94 and women also responded well to motivational techniques, but physical issues presented barriers to PA. The information provided was valued, including increasing awareness of safe PA in pregnancy, and seen to have important educational benefit. Several components of the intervention therefore appeared beneficial and were well received by women. The intervention is relatively intensive and presents costs for providers, and while a full assessment of cost and benefit was not conducted in this pilot, steps taken during the preclinical development phase (using HTs rather than clinicians to deliver the intervention, adopting local group-based approach) helped keep the overall costs of the intervention low, recognising that, if beneficial, it should also be affordable to health providers and to women. The rationale for this choice of HTs to deliver the intervention lay principally in the lower cost of employment compared with trained health professionals, and from our experience in working with Weight Concern, a charity which has pioneered self-help programmes and self-support groups for the treatment of obesity, and which was employed in this programme to train the HTs. All HTs were employed on the basis of having received some training in behaviour change techniques relevant to the delivery of the UPBEAT intervention. Another major advantage is that the expertise required is attainable within the participant materials and HT manuals. This was deliberate, so that it could be delivered by anyone who has received the appropriate training (as delivered as part of the RCT and pilot). Indeed, Weight Concern has previously used a peer-learning approach to good effect; importantly, this enables service providers to adapt the delivery (regarding who is delivering) according to their local population and skill set.
There was also suggestion from the process evaluation that the intervention may extend to peers and family, and some women aspired towards better fitness following birth. This study has reinforced earlier reports suggesting that rapport between study staff and participants, interviews requiring short time commitment and participants’ perception of the study as informative are all important recruitment and retention factors.135 Formal evaluation of the reasons for the high refusal rate was not permissible because of ethical constraints, but the time commitment was frequently commented upon by the recruitment staff, as well as lack of appreciation of the health consequences of obesity in pregnancy.
In summary, this study has emphasised the value of a pilot trial to assess expected behaviour change. Although seldom attempted by others, we have also highlighted the importance of process evaluation in a complex intervention of diet and PA for pregnant women. The pilot trial demonstrated reductions in GL and in the proportion of energy derived from saturated fat are achievable in obese pregnant women without GDM. The process evaluation identified that dietary advice and education were well-received, and confirmed that PA change is more problematic to achieve, although it remains important to consistently measure and support PA using technologies acceptable to women. The process evaluation also helped explain issues arising in relation to uptake, dose, fidelity and retention which informed the feasibility of the full trial.
As a consequence of this study, several modifications to improve compliance and fidelity have now been implemented in the protocol for the main trial. As well as process evaluation, HT feedback highlighted potential barriers to fidelity of the intervention and informed protocol modifications for the RCT. Flexibility has been increased regarding the timing and delivery of the sessions, and goal-setting can be undertaken by telephone or e-mail. It is recommended that women should receive at least five out of eight sessions. The two extra visits required for objective assessment of PA and accurate evaluation of diet have been omitted in all but two sites (as planned) and dietary assessment reduced to a validated FFQ. The RPAQ includes domestic and childcare activities considered appropriate for pregnant women,136 but following feedback has been replaced by the shorter and more relevant International Physical Activity Questionnaire (IPAQ).137 Maintenance of dietary and PA behaviour change in the participant and her family is being formally evaluated at 6 months and at 3 years post partum. Although there was no significant influence of the intervention on objectively measured PA, and only a modest increase in self-reported MVPA, it was decided to continue to recommend PA, as this aligns with best practice as set out in clinical guidelines. To minimise loss to follow-up and attendance at these appointments, strategies that have been put in place include regular newsletters and sending greetings cards on special occasions such as the child’s birthday.
Conclusions
Assumptions should not be made that interventions in obese pregnant women necessarily change behaviour. We recommend that a pilot trial such as that described here, which has demonstrated evidence for expected change in behaviour, is a necessary prelude to any RCT of a complex intervention of diet and PA designed to improve pregnancy outcome in obese women. Without prior evidence for change in behaviour in the expected direction, pursuit of a large and costly trial would be futile. Similarly, we have demonstrated the value of early process evaluation, which can lead to important refinements in protocol to improve feasibility and compliance in the definitive trial.
Implications for proceeding to phase 3, the randomised controlled trial
As detailed in the discussion and conclusion section of the above report, there were many benefits gained from undertaking the pilot trial which led to us to change the delivery of the intervention, but not any of the principal elements of the intervention. Feasibility and general acceptability were established and, most importantly, the intervention led to changed dietary behaviours. PA behaviours that, as we found in the process evaluation, were less amenable to the women proved difficult to change, but the intervention was continued as PA is recommended nationally for all pregnant women. The study also enabled us to better define the power calculations for the main trial, based on the incidence of GDM in the women in the pilot study (see Chapter 4). The process evaluation provided some similar outcomes as structured interviews in phase 1, but several different outcomes, probably because the women in the pilot were more representative of the population to be recruited for the intervention. Importantly, it was recognised that recruitment rates would be lower than expected when the original application for funding was submitted, and that full recruitment to the main UPBEAT intervention would not be feasible within the time frame allotted. Following the pilot trial, an application for an extension to the trial funding was therefore submitted to the National Institute for Health Research (NIHR), and additional funding was provided to allow completion of recruitment.
- The UK Pregnancies Better Eating and Activity trial: phase 2 – pilot trial - Imp...The UK Pregnancies Better Eating and Activity trial: phase 2 – pilot trial - Improving pregnancy outcome in obese women: the UK Pregnancies Better Eating and Activity randomised controlled Trial
Your browsing activity is empty.
Activity recording is turned off.
See more...